beta
Trial Radar AI

Showing clinical trials for Neoplasms matching location: France.

I can help you find clinical trials in specific locations and provide insights on health conditions and treatments.

With advanced mode, access powerful pre-screening tools, interactive data visualizations, customized email alerts for trial updates and more.

13 Results
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Condition
Neoplasms
×
 
Keywords
Adaptive immune responses
×
 
Location
France
×
 
Study Title
Status
Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy (MINER) NCT03514368
Recruiting
Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy of Immunotherapy in Patients With Early Stage Cancer (MINER2) NCT07427186
Not yet recruiting
Immune Response to Immunotherapy in Lung Cancer: Study of Sputum and Blood Samples (RICEPS-2) NCT07163507
Not yet recruiting
Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA NCT05354765
Recruiting
Neo-adjuvant Immunotherapy Master Trial for Localized Cancers (NEOREM) NCT07262489
Recruiting
Characterisation of TLR4+ Blood Cells in Patients With Solid Cancer (ODYSSEE) NCT06131775
Recruiting
Impact of Dysbiosis-inducing Drugs on Effectivity of Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer Patients (ICI) NCT07191171
Recruiting
Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients (NEOEPICURE) NCT05981326
Recruiting
Dynamics of Resistance Emergence to Azacitidine-based Therapies in Acute Myeloid Leukemia (DREAM) NCT06225128
Recruiting
A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Collection of Multimodal Data (Including Clinical Data, Imaging Data and Omics Data) in Oncology (MOSAIC) NCT06625203
Recruiting
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. (SYMPHONY-1) NCT04224493
Recruiting
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma (CERVINO) NCT06158841
Recruiting
Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia (QOLIBRI) NCT06299540
Recruiting